Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Launch date
Employees
Market cap
€203m
Enterprise valuation
(€19m) (Public information from May 2024)
Share price
$15.13 MACK
Cambridge Massachusetts (HQ)
Authorizing premium user...